WA Wildlife reports rise in mysterious syndrome harming the State's iconic black swans
WA Wildlife has reported a considerable rise in a mysterious syndrome harming the State's black swans.
The not-for-profit organisation said it is treating an increasing number of black swans for a photosensitivity syndrome.
'Over the past few months, WA Wildlife has observed a notable increase in black swans presenting with a mysterious photosensitivity syndrome, particularly around the Swan River,' the Bibra Lake-based organisation wrote in a Facebook post on Monday.
'While we typically see just a handful of cases each year, we've treated over 20 swans in 2025 alone, most rescued by our friends at WA Seabird Rescue.'
The birds — which appear on the State's flag — have been suffering from painful symptoms.
The rescue centre said the cause of the syndrome is unknown, but claimed it could be linked to toxic exposure or liver dysfunction from environmental triggers. These factors increase the sensitivity of the skin to sunlight.
Fortunately, WA Wildlife said the majority of swans see improvement in their symptoms.
'Most birds recover well with dedicated supportive care, including pain management, wound treatment and time in UV-protected enclosures to prevent further damage,' it wrote.
According to the WA Wildlife website, the native wildlife hospital treats more than 6500 animals from 280 species each year.
Magpies across WA have also fallen victim to a mysterious syndrome, however, this particular disease is deadly.
It is estimated hundreds of thousands of the birds have suffered from magpie paralysis syndrome, also known as black and white bird paralysis, with cases rising in spring and summer.
CEO of WA Wildlife, Dean Huxley, said the mass deaths 'feel almost apocalyptic'.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Advertiser
a day ago
- The Advertiser
'I was going downhill fast': breast cancer drug gives new lease on life
Mayfield's Madelaine Atkins has a new lease on life from a drug trial that aims to treat advanced breast cancer. She's been part of the FINER clinical trial through the Newcastle-based Breast Cancer Trials for three and a half years. It aims to keep metastatic breast cancer under control for longer. "I feel fantastic. It's created a quality life and freedom for me," said Ms Atkins, 67. "Before I went on the drug trial, I was going downhill fast. My weight was dropping and I was feeling sick and weak." The trial enrolled 250 female and male patients with "advanced ER-positive and HER2-negative breast cancer". The results showed that the addition of the drug ipatasertib to standard treatment "controlled the progress of metastatic breast cancer for almost three times as long". "The main objective of this study was to examine whether treatment with ipatasertib plus fulvestrant was better than fulvestrant alone." Associate Professor Andrew Redfern, chair of the FINER trial, said the results were "significant for these patients with advanced disease". "It could potentially help up to 1500 people in Australia every year who are diagnosed with this type of breast cancer," A/Prof Redfern said. "We now need to confirm these results with longer follow-up of the patients on this trial, as well as further research." Ms Atkins was diagnosed at age 50. "I did chemotherapy, radiation and breast removal," she said. "When I was 60, the little devil came back. It was in my shoulder and started to go up my neck." FINER is a "double-blind placebo-controlled randomised trial". "You don't know which one you get [the drug or placebo]. But here I am, touch wood, in fabulous health with no complaints. It has truly been a blessing to me. "I'm a very positive person. My ethos was I'm not finished yet, so let the game begin." As part of the trial, she receives an "injection in my bottom" each month at Lake Macquarie Private. "We're very lucky to have such great nurses and doctors in Newcastle, let alone Australia," she said. "They'll do anything they can to make your journey that little bit better." She said her partner's support and staying social helped her health journey. "I've been fortunate not to need to work, so I've gone into semi-retirement. "We get away every couple of weeks. It adds that life balance. I'm blessed with great family and friends. "I've enjoyed my life. There's nothing I'd want for except a nice life expectancy." She said there was an upside to going through health challenges. "It shatters you to hear those words [a cancer diagnosis], but it's a strange thing how it can be a blessing," she said. "It wasn't like I got hit by the 207 Merewether bus. If you get hit by a bus, you never get to say goodbye." She said early intervention was key. "I rubbed my neck and it felt like a little pimple the size of a pinhead," she said. "Get it while it's timely and we've got a chance. Let it get to the size of a pea and it's a bigger battle. Get to a strawberry and it's a longer journey." Mayfield's Madelaine Atkins has a new lease on life from a drug trial that aims to treat advanced breast cancer. She's been part of the FINER clinical trial through the Newcastle-based Breast Cancer Trials for three and a half years. It aims to keep metastatic breast cancer under control for longer. "I feel fantastic. It's created a quality life and freedom for me," said Ms Atkins, 67. "Before I went on the drug trial, I was going downhill fast. My weight was dropping and I was feeling sick and weak." The trial enrolled 250 female and male patients with "advanced ER-positive and HER2-negative breast cancer". The results showed that the addition of the drug ipatasertib to standard treatment "controlled the progress of metastatic breast cancer for almost three times as long". "The main objective of this study was to examine whether treatment with ipatasertib plus fulvestrant was better than fulvestrant alone." Associate Professor Andrew Redfern, chair of the FINER trial, said the results were "significant for these patients with advanced disease". "It could potentially help up to 1500 people in Australia every year who are diagnosed with this type of breast cancer," A/Prof Redfern said. "We now need to confirm these results with longer follow-up of the patients on this trial, as well as further research." Ms Atkins was diagnosed at age 50. "I did chemotherapy, radiation and breast removal," she said. "When I was 60, the little devil came back. It was in my shoulder and started to go up my neck." FINER is a "double-blind placebo-controlled randomised trial". "You don't know which one you get [the drug or placebo]. But here I am, touch wood, in fabulous health with no complaints. It has truly been a blessing to me. "I'm a very positive person. My ethos was I'm not finished yet, so let the game begin." As part of the trial, she receives an "injection in my bottom" each month at Lake Macquarie Private. "We're very lucky to have such great nurses and doctors in Newcastle, let alone Australia," she said. "They'll do anything they can to make your journey that little bit better." She said her partner's support and staying social helped her health journey. "I've been fortunate not to need to work, so I've gone into semi-retirement. "We get away every couple of weeks. It adds that life balance. I'm blessed with great family and friends. "I've enjoyed my life. There's nothing I'd want for except a nice life expectancy." She said there was an upside to going through health challenges. "It shatters you to hear those words [a cancer diagnosis], but it's a strange thing how it can be a blessing," she said. "It wasn't like I got hit by the 207 Merewether bus. If you get hit by a bus, you never get to say goodbye." She said early intervention was key. "I rubbed my neck and it felt like a little pimple the size of a pinhead," she said. "Get it while it's timely and we've got a chance. Let it get to the size of a pea and it's a bigger battle. Get to a strawberry and it's a longer journey." Mayfield's Madelaine Atkins has a new lease on life from a drug trial that aims to treat advanced breast cancer. She's been part of the FINER clinical trial through the Newcastle-based Breast Cancer Trials for three and a half years. It aims to keep metastatic breast cancer under control for longer. "I feel fantastic. It's created a quality life and freedom for me," said Ms Atkins, 67. "Before I went on the drug trial, I was going downhill fast. My weight was dropping and I was feeling sick and weak." The trial enrolled 250 female and male patients with "advanced ER-positive and HER2-negative breast cancer". The results showed that the addition of the drug ipatasertib to standard treatment "controlled the progress of metastatic breast cancer for almost three times as long". "The main objective of this study was to examine whether treatment with ipatasertib plus fulvestrant was better than fulvestrant alone." Associate Professor Andrew Redfern, chair of the FINER trial, said the results were "significant for these patients with advanced disease". "It could potentially help up to 1500 people in Australia every year who are diagnosed with this type of breast cancer," A/Prof Redfern said. "We now need to confirm these results with longer follow-up of the patients on this trial, as well as further research." Ms Atkins was diagnosed at age 50. "I did chemotherapy, radiation and breast removal," she said. "When I was 60, the little devil came back. It was in my shoulder and started to go up my neck." FINER is a "double-blind placebo-controlled randomised trial". "You don't know which one you get [the drug or placebo]. But here I am, touch wood, in fabulous health with no complaints. It has truly been a blessing to me. "I'm a very positive person. My ethos was I'm not finished yet, so let the game begin." As part of the trial, she receives an "injection in my bottom" each month at Lake Macquarie Private. "We're very lucky to have such great nurses and doctors in Newcastle, let alone Australia," she said. "They'll do anything they can to make your journey that little bit better." She said her partner's support and staying social helped her health journey. "I've been fortunate not to need to work, so I've gone into semi-retirement. "We get away every couple of weeks. It adds that life balance. I'm blessed with great family and friends. "I've enjoyed my life. There's nothing I'd want for except a nice life expectancy." She said there was an upside to going through health challenges. "It shatters you to hear those words [a cancer diagnosis], but it's a strange thing how it can be a blessing," she said. "It wasn't like I got hit by the 207 Merewether bus. If you get hit by a bus, you never get to say goodbye." She said early intervention was key. "I rubbed my neck and it felt like a little pimple the size of a pinhead," she said. "Get it while it's timely and we've got a chance. Let it get to the size of a pea and it's a bigger battle. Get to a strawberry and it's a longer journey." Mayfield's Madelaine Atkins has a new lease on life from a drug trial that aims to treat advanced breast cancer. She's been part of the FINER clinical trial through the Newcastle-based Breast Cancer Trials for three and a half years. It aims to keep metastatic breast cancer under control for longer. "I feel fantastic. It's created a quality life and freedom for me," said Ms Atkins, 67. "Before I went on the drug trial, I was going downhill fast. My weight was dropping and I was feeling sick and weak." The trial enrolled 250 female and male patients with "advanced ER-positive and HER2-negative breast cancer". The results showed that the addition of the drug ipatasertib to standard treatment "controlled the progress of metastatic breast cancer for almost three times as long". "The main objective of this study was to examine whether treatment with ipatasertib plus fulvestrant was better than fulvestrant alone." Associate Professor Andrew Redfern, chair of the FINER trial, said the results were "significant for these patients with advanced disease". "It could potentially help up to 1500 people in Australia every year who are diagnosed with this type of breast cancer," A/Prof Redfern said. "We now need to confirm these results with longer follow-up of the patients on this trial, as well as further research." Ms Atkins was diagnosed at age 50. "I did chemotherapy, radiation and breast removal," she said. "When I was 60, the little devil came back. It was in my shoulder and started to go up my neck." FINER is a "double-blind placebo-controlled randomised trial". "You don't know which one you get [the drug or placebo]. But here I am, touch wood, in fabulous health with no complaints. It has truly been a blessing to me. "I'm a very positive person. My ethos was I'm not finished yet, so let the game begin." As part of the trial, she receives an "injection in my bottom" each month at Lake Macquarie Private. "We're very lucky to have such great nurses and doctors in Newcastle, let alone Australia," she said. "They'll do anything they can to make your journey that little bit better." She said her partner's support and staying social helped her health journey. "I've been fortunate not to need to work, so I've gone into semi-retirement. "We get away every couple of weeks. It adds that life balance. I'm blessed with great family and friends. "I've enjoyed my life. There's nothing I'd want for except a nice life expectancy." She said there was an upside to going through health challenges. "It shatters you to hear those words [a cancer diagnosis], but it's a strange thing how it can be a blessing," she said. "It wasn't like I got hit by the 207 Merewether bus. If you get hit by a bus, you never get to say goodbye." She said early intervention was key. "I rubbed my neck and it felt like a little pimple the size of a pinhead," she said. "Get it while it's timely and we've got a chance. Let it get to the size of a pea and it's a bigger battle. Get to a strawberry and it's a longer journey."
West Australian
a day ago
- West Australian
June push-up challenge for headspace Margaret River to spotlight national suicide crisis
Community members are being encouraged to get involved in the local headspace's June Push-Up Challenge. Headspace offices across the country are taking up the task to complete 3214 push-ups in 23 days to honour the number of lives lost to suicide in Australia in 2023. Margaret River-based co-ordinator Dorian De Nobrega said there were great reasons to join the Push-Up Challenge. 'When people register for the challenge, they can choose to help raise vital funds for headspace to support our national youth mental health programs, or directly support their local headspace centre in Bunbury, Busselton or Margaret River,' he said. 'By participating and raising funds for headspace, we will be able to pilot new and innovative programs, grow our reach, and improve mental health outcomes of young people living in the region.' The Push-Up Challenge was created to promote awareness and encourage positive mental health, Mr De Nobrega said. The challenge is described as 'a fun and unique way to engage friends, family, colleagues and community in mental health through connection, physical activity and education'. 'Not only is the challenge lots of fun, but the visibility of it also means it generates conversations in our communities,' Mr De Nobrega said. 'These conversations help to reduce the stigma about mental ill health and encourage seeking help so people who are experiencing challenges don't feel so alone.' Mr De Nobrega stressed participants didn't have to be athletes or undertake any gruelling training regimen. They could instead complete half-push-ups, split the load with a friend, or substitute push-ups for less stressful movements like squats or burpees. To register and find out more, visit .
7NEWS
2 days ago
- 7NEWS
Named and shamed: Swadesh Indian Restaurant in Baldivis hit with $40k fine for filthy kitchen
An Indian restaurant in Baldivis has been slapped with a fine over a filthy kitchen and dodgy hygiene practices. The owners of Swadesh Indian Restaurant, which has four-and-a-half stars on Google, were fined $40,000 and ordered to pay $24,000 in costs after health inspectors found the kitchen was not up to scratch. The restaurant opened in 2018 and attracts a swathe of good reviews from locals who praise the freshness of dishes and delicious flavours. On Facebook, the team promises to provide 'the freshest ingredients, highest possible quality, all beautifully prepared and presented so that a typical dinner becomes a great experience'. But Swadesh's kitchen has not been up to standard since 2022, when City of Rockingham inspectors found food was not stored in a way to prevent contamination, handwashing facilities were not maintained and there was an accumulation of food waste, dirt and grease. When inspectors returned in 2023, they found the kitchen still hadn't been maintained to the expected standard, with handwashing and dirty equipment found to be a problem yet again. The $40,000 fine is the biggest handed down to a food business in 2025. Last year, Lavoro Italiano Restaurant, also in the City of Rockingham, was fined the same amount when inspectors found crawling cockroaches and cigarette butts in the dry storage. Prosecutors described the kitchen as one of the worst they'd seen in WA, saying: 'Cockroaches seen during the day indicates a serious infestation. When they were pointed out, the owner was not surprised'. But a Nandos in Willetton copped the biggest fine of 2024 when it was hit with $160,000 for being filthy, crawling with rats and selling food past its use-by date. This was followed by Belmont-based Aquarium Seafood Chinese Restaurant, which was fined $80,000 for being filthy and riddled with pests.
